Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02610777
Brief Title: An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

First Submitted : November 18, 2015
First Submitted that Met QC Criteria : November 19, 2015
First Posted : November 20, 2015 (Estimate)

Results First Submitted : August 31, 2020
Results First Submitted that Met QC Criteria : August 31, 2020
Results First Posted : September 23, 2020

Last Update Submitted that Met QC Criteria : December 16, 2020
Last Update Posted : January 6, 2021